SynthesisScientific reports2020

Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis.

Leitao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.